Skip to content

Effectiveness of Motivation-Skill-Desensitization-mental Energy (MSDE) intervention model on relapse prevention among heroin addicts: A randomized controlled trial

A clinical research of neurotransmitters psychology energy supply model on drug relapse prevention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007094
Enrollment
Unknown
Registered
2015-09-15
Start date
2015-09-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Addiction

Interventions

conventional treatment control :conventional detoxification treatment routine rehabilitation training
motivation enhancement control :motivation enhancement therapy
MET+ST intervention :motivation enhancement therapy skill training
MET+EMDR intervention :motivation enhancement therapy eye movement desensitization reprocessing
MET+MG intervention :motivation enhancement therapy mental growth
MET+ST+EMDR intervention :motivation enhancement therapy skill training eye movement desensitization reprocessing
MET+ST+EMDR+MG intervention :motivation enhancement therapy skill training eye movement desensitization reprocessing mental growth

Sponsors

Department of Epidemiology Health Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) History of drug abuse 6 months before entering the compulsory rehabilitation center; (2) opiod dependence as diagnosed through International Classification of Diseases (ICD-10); (3) 18 to 55 years old; (4) Receiving detoxification treatment for at least 15 days; (5) Fully understthe contents of research willing to participate in the research.

Exclusion criteria

Exclusion criteria: (1) High myopia (600-degree or above) or other ophthalmic diseases; (2) Hypertension (SBP>=140mmHg, DBP>=90mmHg); (3) Severe cardiovascular diseases; (4) History of nervous tem diseases; (5) History of mental disorders; (6) History of epilepsy; (7) Other severe diseases needed to receive medication.

Design outcomes

Primary

MeasureTime frame
University of Rhode IslChange Assessment Scale;Self-designed Mastery of Skill Rating Scale;Addiction Memory Rating Scale;Self-Rating Depression Scale;Positive Energy Rating Scale;Family APGAR Index;Community Support Rating Scale;abstinence rate;

Countries

China

Contacts

Public ContactZengzhen WANG
zzhwang@hust.edu.cn+86 027 83657775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026